BridgeBio Pharma Other Non-Current Liabilities 2018-2025 | BBIO
BridgeBio Pharma other non-current liabilities for the quarter ending March 31, 2025 were $0.498B, a 83538.82% increase year-over-year.
- BridgeBio Pharma other non-current liabilities for 2024 were $0.479B, a 8408.64% increase from 2023.
- BridgeBio Pharma other non-current liabilities for 2023 were $0.006B, a 78.85% decline from 2022.
- BridgeBio Pharma other non-current liabilities for 2022 were $0.027B, a 20.73% increase from 2021.